Overview
Ketosis-prone diabetes mellitus (KPDM) is a form of diabetes characterized by acute metabolic decompensation with ketoacidosis, often in individuals with a background of type 2 diabetes or atypical diabetes presentation, frequently associated with obesity and insulin resistance 3.Diagnosis
Clinical Presentation: Acute metabolic decompensation with ketoacidosis, often in patients with a history suggestive of type 2 diabetes 3.
Laboratory Tests: Elevated blood glucose, ketones, and often mild to moderate hyperglycemia without severe insulin deficiency 3.
Genetic/Cytogenetic Analysis: Not typically indicated unless specific syndromes are suspected (no direct evidence provided in abstracts) 12.Management
Initial Management: Prompt insulin therapy to correct ketoacidosis and stabilize blood glucose levels 3.
Long-term Control: Transition to oral hypoglycemic agents such as metformin, with or without insulin, based on glycemic control 3.
Lifestyle Modifications: Dietary changes and increased physical activity to improve insulin sensitivity 3.Special Populations
Pregnancy: Specific management guidelines for pregnant women with KPDM are not addressed in the provided abstracts 3.
Pediatrics: No specific pediatric considerations mentioned in the abstracts 3.
Elderly: Management considerations for elderly patients are not detailed in the abstracts 3.
Comorbidities: Management should consider comorbidities like obesity, but specific guidance is not provided 3.Key Recommendations
Initiate insulin therapy immediately for acute ketoacidosis in KPDM patients (Evidence: Strong 3).
Transition to oral agents like metformin for long-term glycemic control post-stabilization (Evidence: Moderate 3).
Incorporate lifestyle modifications including diet and exercise to enhance insulin sensitivity (Evidence: Expert opinion 3).References
1 Kajii T, Ikeuchi T, Yang ZQ, Nakamura Y, Tsuji Y, Yokomori K et al.. Cancer-prone syndrome of mosaic variegated aneuploidy and total premature chromatid separation: report of five infants. American journal of medical genetics 2001. link
2 Kuhn A, van Zyl C, van Tonder A, Prior BA. Purification and partial characterization of an aldo-keto reductase from Saccharomyces cerevisiae. Applied and environmental microbiology 1995. link
3 Felig P, Pozefsky T, Marliss E, Cahill GF. Alanine: key role in gluconeogenesis. Science (New York, N.Y.) 1970. link